Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-12 Sale |
2025-03-14 8:33 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
607 | $44.88 | $27,242 | 260,540 (Indirect Direct) |
View |
2025-03-04 Sale |
2025-03-05 6:56 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
50,000 | $44.86 | $2,243,213 | 261,147 (Indirect Direct) |
View |
2025-02-03 Sale |
2025-02-05 09:03 am |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $53.81 | $538,061 | 311,147 (Indirect Direct) |
View |
2025-01-02 Sale |
2025-01-06 2:08 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $28.03 | $280,330 | 278,083 (Indirect Direct) |
View |
2024-12-10 Sale |
2024-12-12 8:38 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
2,503 | $30.79 | $77,067 | 263,783 (Indirect Direct) |
View |
2024-12-02 Sale |
2024-12-04 7:34 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $32.13 | $321,310 | 266,286 (Indirect Direct) |
View |
2024-11-01 Sale |
2024-11-05 09:04 am |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
50,716 | $31.57 | $1,601,252 | 276,286 (Indirect Direct) |
View |
2024-10-14 Sale |
2024-10-16 8:06 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,000 | $30.15 | $1,206,080 | 327,002 (Indirect Direct) |
View |
2024-10-01 Sale |
2024-10-03 8:09 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
10,000 | $28.18 | $281,770 | 286,286 (Indirect Direct) |
View |
2024-09-10 Sale |
2024-09-13 5:16 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
568 | $26.18 | $14,870 | 296,286 (Indirect Direct) |
View |
2024-09-03 Sale |
2024-09-05 4:08 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $26.72 | $133,588 | 296,854 (Indirect Direct) |
View |
2024-08-01 Sale |
2024-08-02 9:32 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $26.75 | $133,756 | 301,854 (Indirect Direct) |
View |
2024-07-01 Sale |
2024-07-02 6:55 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $23.4 | $117,020 | 306,854 (Indirect Direct) |
View |
2024-06-11 Sale |
2024-06-13 6:13 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
2,516 | $22.64 | $56,965 | 310,790 (Indirect Direct) |
View |
2024-06-03 Sale |
2024-06-05 5:05 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $19.29 | $96,440 | 313,306 (Indirect Direct) |
View |
2024-05-01 Sale |
2024-05-02 9:07 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $20.15 | $100,750 | 318,306 (Indirect Direct) |
View |
2024-04-01 Sale |
2024-04-03 6:55 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,000 | $24.38 | $121,913 | 323,306 (Indirect Direct) |
View |
2024-03-13 Sale |
2024-03-15 4:42 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
651 | $28.33 | $18,443 | 328,306 (Indirect Direct) |
View |
2023-12-27 Sale |
2023-12-29 8:30 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,414 | $24 | $129,936 | 288,195 (Indirect Direct) |
View |
2023-12-14 Sale |
2023-12-18 8:39 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
543 | $20.76 | $11,273 | 245,131 (Indirect Direct) |
View |
2023-11-17 Sale |
2023-11-21 5:30 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
30,000 | $14.68 | $440,259 | 213,177 (Indirect Direct) |
View |
2023-10-02 Sale |
2023-10-04 8:33 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
490 | $51.1 | $25,039 | 329,908 (Indirect Direct) |
View |
2023-09-13 Sale |
2023-09-25 8:28 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
562 | $50.34 | $28,291 | 243,177 (Indirect Direct) |
View |
2023-06-13 Sale |
2023-06-15 9:35 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
538 | $55.16 | $29,676 | 243,739 (Indirect Direct) |
View |
2023-01-03 Sale |
2023-01-05 5:56 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
8,777 | $54.64 | $479,560 | 328,232 (Indirect Direct) |
View |
2022-12-27 Sale |
2022-12-28 6:30 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $49.57 | $619,609 | 383,025 (Indirect Direct) |
View |
2022-10-25 Sale |
2022-10-27 9:25 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $44.72 | $558,944 | 283,510 (Indirect Direct) |
View |
2021-11-03 Sale |
2021-11-05 4:17 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
25,000 | $24.28 | $607,123 | 195,510 (Indirect Direct) |
View |
2021-09-01 Sale |
2021-09-03 4:38 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $24.04 | $300,500 | 220,510 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-24 Exercise |
2025-01-27 6:08 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
43,064 | $6.364 | 321,147 (Direct) |
View |
2025-01-23 Exercise |
2025-01-27 6:08 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
43,064 | $0 | 321,147 (Direct) |
View |
2024-12-16 Option Award |
2024-12-18 9:08 pm |
N/A 2034-12-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
98,000 | $0 | 361,783 (Direct) |
View |
2024-11-01 Exercise |
2024-11-05 09:04 am |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,716 | $0 | 276,286 (Direct) |
View |
2024-11-01 Exercise |
2024-11-05 09:04 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,716 | $21.09 | 276,286 (Direct) |
View |
2024-10-14 Exercise |
2024-10-16 8:06 pm |
N/A 2029-12-12 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,000 | $0 | 327,002 (Direct) |
View |
2024-10-14 Exercise |
2024-10-16 8:06 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
40,000 | $21.09 | 327,002 (Direct) |
View |
2024-06-28 Option Award |
2024-07-02 6:55 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
1,064 | $19.94 | 306,854 (Direct) |
View |
2024-03-01 Exercise |
2024-03-05 5:16 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
83,321 | $0 | 328,957 (Direct) |
View |
2024-03-01 Exercise |
2024-03-05 5:16 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
83,321 | $0.615 | 328,957 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 8:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,414 | $6.36 | 288,195 (Direct) |
View |
2023-12-27 Exercise |
2023-12-29 8:30 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,414 | $0 | 288,195 (Direct) |
View |
2023-12-08 Option Award |
2023-12-12 4:43 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
178,734 | $0 | 391,911 (Direct) |
View |
2023-10-02 Exercise |
2023-10-04 8:33 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
490 | $0 | 329,908 (Direct) |
View |
2023-10-02 Exercise |
2023-10-04 8:33 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
490 | $21.1 | 329,908 (Direct) |
View |
2023-03-10 Tax Withholding |
2023-03-14 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
634 | $43.47 | 244,277 (Direct) |
View |
2023-01-03 Exercise |
2023-01-05 5:56 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
8,777 | $0 | 328,232 (Direct) |
View |
2023-01-03 Exercise |
2023-01-05 5:56 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
8,777 | $0.615 | 328,232 (Direct) |
View |
2022-12-27 Exercise |
2022-12-28 6:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
11,778 | $6.36 | 383,025 (Direct) |
View |
2022-12-27 Exercise |
2022-12-28 6:30 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $0 | 383,025 (Direct) |
View |
2022-12-27 Exercise |
2022-12-28 6:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
722 | $0.615 | 383,025 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 7:49 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
29,073 | $0 | 87,221 (Direct) |
View |
2022-12-09 Option Award |
2022-12-13 8:30 pm |
N/A 2032-12-08 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
105,574 | $0 | 328,828 (Direct) |
View |
2022-10-25 Exercise |
2022-10-27 9:25 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $6.36 | 283,510 (Direct) |
View |
2022-10-25 Exercise |
2022-10-27 9:25 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
12,500 | $0 | 283,510 (Direct) |
View |
2022-09-09 Option Award |
2022-09-13 9:16 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
58,148 | $0 | 87,222 (Direct) |
View |
2022-01-07 Exercise |
2022-01-11 4:40 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
27,744 | $0 | 316,074 (Direct) |
View |
2022-01-07 Exercise |
2022-01-11 4:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
27,744 | $0.615 | 316,074 (Direct) |
View |
2021-12-08 Option Award |
2021-12-10 5:06 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
87,221 | $0 | 87,221 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A 2028-07-29 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
9,000 | $0 | 259,306 (Direct) |
View |
2021-07-15 Exercise |
2021-07-19 4:43 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
9,000 | $0.615 | 259,306 (Direct) |
View |